{"id":62460,"date":"2026-01-08T10:06:13","date_gmt":"2026-01-08T09:06:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/"},"modified":"2026-01-08T10:06:13","modified_gmt":"2026-01-08T09:06:13","slug":"fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/","title":{"rendered":"FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference"},"content":{"rendered":"<div>\n<p>PORTO, Portugal&#8211;(BUSINESS WIRE)&#8211;FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking place from January 12 \u2013 15, 2026 in San Francisco, CA.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20260107319484\/en\/2685542\/5\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260107319484\/en\/2685542\/22\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20260107319484\/en\/2685542\/5\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260107319484\/en\/2685542\/21\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg\"><\/a><\/p>\n<p>\nWith more than a decade of expertise, FJBio has supported over 250 clients across Pharma, Biotech and Academia and contributed to more than 19 antibodies advancing to clinical stage development or the market. During his presentation, Dr. Lanthaler will address FJBio\u2019s strategic positioning as a highly efficient, integrated partner. He will showcase the Company\u2019s antibody discovery and development solutions, with a focus on innovation, data-driven platforms and scalable collaboration models across the biopharmaceutical ecosystem.<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl bwwidth100\">\n<tr>\n<td class=\"bwvertalignt bwpadl0 bwrowaltcolor1 bwwidth22\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nPresenter<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwrowaltcolor1 bwwidth12\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nRole<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwrowaltcolor1 bwwidth7\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nDate<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwrowaltcolor1 bwwidth16\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nTime<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwrowaltcolor1 bwwidth43\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nVenue<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0 bwwidth22 bwvertalignb\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nDr. Werner Lanthaler<\/p>\n<\/td>\n<td class=\"bwpadl0 bwwidth12 bwvertalignb\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nCEO, FJBio<\/p>\n<\/td>\n<td class=\"bwpadl0 bwwidth7 bwvertalignb\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nJan 13<\/p>\n<\/td>\n<td class=\"bwpadl0 bwwidth16 bwvertalignb\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n09:00\u201309:25 AM<\/p>\n<\/td>\n<td class=\"bwpadl0 bwwidth43 bwvertalignb\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u201cGolden Gate\u201d at THE WESTIN, 32<sup>nd<\/sup> floor<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nIn addition to the CEO presentation, members of FJBio\u2019s Senior Management and Business Development teams will attend the conference for strategic discussions with representatives of global pharmaceutical companies, biotechnology innovators and other industry partners throughout the event.<\/p>\n<p>\n<b>Dr. Werner Lanthaler, Chief Executive Officer of FairJourney Bio, commented:<\/b> <i>\u201cI look forward to presenting FairJourney Bio\u2019s unique platform for partnered pipeline building at this year\u2019s J.P. Morgan 2026 Healthcare Conference. This conference brings together a highly curated group of global healthcare leaders and innovators and I appreciate the opportunity to engage in meaningful dialogue around the future of efficient, data-enabled antibody discovery and development.\u201d<\/i><\/p>\n<p>\nParticipation as a presenting company at this conference is highly selective and considered a significant distinction, reflecting FJBio\u2019s growing global recognition and relevance within the international life sciences community. The conference provides an important platform for FJBio to strengthen existing relationships, explore new strategic partnerships and further position the Company as a trusted global partner across the full value chain.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>FairJourney Biologics<\/b><br \/>Hinnerk Rohwedder<br \/>\n<br \/>Head of Marketing &amp; Communications<br \/>\n<br \/><a target=\"_blank\" href=\"mail&#116;&#111;&#58;&#104;&#114;&#x6f;&#x68;&#x77;&#x65;&#x64;&#x64;&#x65;r&#64;fj&#98;&#105;&#111;&#46;&#99;&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#104;&#x72;&#111;&#x68;w&#x65;d&#100;&#x65;&#114;&#x40;f&#x6a;b&#105;&#x6f;&#46;&#x63;o&#x6d;<\/a><\/p>\n<p>\n<b>Zyme Communications<br \/>\n<br \/><\/b>Lily Jeffery<b><br \/><\/b>Email: <a target=\"_blank\" href=\"&#x6d;&#x61;&#105;lt&#x6f;&#x3a;&#108;&#105;l&#x79;&#x2e;&#106;&#101;f&#x66;&#x65;&#x72;&#121;&#64;z&#x79;&#x6d;&#101;&#99;o&#x6d;&#x6d;&#117;&#110;i&#x63;&#x61;&#116;&#105;o&#x6e;&#x73;&#x2e;&#99;om\" rel=\"nofollow\" shape=\"rect\">&#x6c;i&#x6c;&#121;&#46;&#x6a;&#101;&#x66;&#102;e&#x72;&#121;&#x40;&#122;y&#x6d;&#101;&#x63;&#x6f;m&#x6d;&#117;n&#x69;&#99;&#x61;&#116;i&#x6f;&#110;&#x73;&#46;c&#x6f;&#109;<\/a><br \/>Tel: +44 (0)7891 477 378<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PORTO, Portugal&#8211;(BUSINESS WIRE)&#8211;FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking place from January 12 \u2013 15, 2026 in San Francisco, CA. With more than a decade of expertise, FJBio has supported over &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62460","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PORTO, Portugal&#8211;(BUSINESS WIRE)&#8211;FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking place from January 12 \u2013 15, 2026 in San Francisco, CA. With more than a decade of expertise, FJBio has supported over ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-08T09:06:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260107319484\/en\/2685542\/22\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference\",\"datePublished\":\"2026-01-08T09:06:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\\\/\"},\"wordCount\":334,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260107319484\\\/en\\\/2685542\\\/22\\\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\\\/\",\"name\":\"FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260107319484\\\/en\\\/2685542\\\/22\\\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg\",\"datePublished\":\"2026-01-08T09:06:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260107319484\\\/en\\\/2685542\\\/22\\\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260107319484\\\/en\\\/2685542\\\/22\\\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference - Pharma Trend","og_description":"PORTO, Portugal&#8211;(BUSINESS WIRE)&#8211;FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking place from January 12 \u2013 15, 2026 in San Francisco, CA. With more than a decade of expertise, FJBio has supported over ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2026-01-08T09:06:13+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260107319484\/en\/2685542\/22\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference","datePublished":"2026-01-08T09:06:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/"},"wordCount":334,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260107319484\/en\/2685542\/22\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/","name":"FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260107319484\/en\/2685542\/22\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg","datePublished":"2026-01-08T09:06:13+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260107319484\/en\/2685542\/22\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260107319484\/en\/2685542\/22\/NEW_JAN_2026_FairJourneyBio-Logo-RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/fairjourney-bio-to-present-at-j-p-morgan-2026-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62460"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62460\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}